Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Bernstein

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Hematology. American Society of Hematology. Education Program|December 17, 2009
The incidence, natural history, biology, and treatment of transformed lymphomasSteven H Bernstein, W Richard Burack
Immunological Investigations|December 29, 2007
Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsiesShannon P Hilchey, Steven H Bernstein
Leukemia Research|December 5, 2003
Inhibition of cyclooxygenase-2: a new targeted therapy for B-cell lymphoma?Richard P Phipps, Elizabeth Ryan, Steven H Bernstein
Clinical Immunology (Orlando, Fla.)|September 29, 2004
Human multiple myeloma cells express peroxisome proliferator-activated receptor gamma and undergo apoptosis upon exposure to PPARgamma ligandsDenise M Ray, Steven H Bernstein, Richard P Phipps
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cellsTatiana M Garcia-Bates, Steven H Bernstein, Richard P Phipps
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
CD40 engagement prevents peroxisome proliferator-activated receptor gamma agonist-induced apoptosis of B lymphocytes and B lymphoma cells by an NF-kappaB-dependent mechanismDenise M Ray, Filiz Akbiyik, Steven H Bernstein, et al.
Leukemia Research|August 10, 2011
Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphomaStephanie J Carter, Steven H Bernstein, Jonathan W Friedberg, et al.
Journal of Clinical Pharmacology|May 23, 2002
Pharmacodynamic modeling of thrombopoietin, platelet, and megakaryocyte dynamics in patients with acute myeloid leukemia undergoing dose intensive chemotherapySteven H Bernstein, William J Jusko, Wojciech Krzyzanski, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 8, 2013
Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease statesMaria Serena Longhi, Simon C Robson, Steven H Bernstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
Follicular lymphoma intratumoral CD4+CD25+GITR+ regulatory T cells potently suppress CD3/CD28-costimulated autologous and allogeneic CD8+CD25- and CD4+CD25- T cellsShannon P Hilchey, Asit De, Lisa M Rimsza, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Hematology. American Society of Hematology. Education Program|December 17, 2009
The incidence, natural history, biology, and treatment of transformed lymphomasSteven H Bernstein, W Richard Burack
Immunological Investigations|December 29, 2007
Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsiesShannon P Hilchey, Steven H Bernstein
Leukemia Research|December 5, 2003
Inhibition of cyclooxygenase-2: a new targeted therapy for B-cell lymphoma?Richard P Phipps, Elizabeth Ryan, Steven H Bernstein
Clinical Immunology (Orlando, Fla.)|September 29, 2004
Human multiple myeloma cells express peroxisome proliferator-activated receptor gamma and undergo apoptosis upon exposure to PPARgamma ligandsDenise M Ray, Steven H Bernstein, Richard P Phipps
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cellsTatiana M Garcia-Bates, Steven H Bernstein, Richard P Phipps
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
CD40 engagement prevents peroxisome proliferator-activated receptor gamma agonist-induced apoptosis of B lymphocytes and B lymphoma cells by an NF-kappaB-dependent mechanismDenise M Ray, Filiz Akbiyik, Steven H Bernstein, et al.
Leukemia Research|August 10, 2011
Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphomaStephanie J Carter, Steven H Bernstein, Jonathan W Friedberg, et al.
Journal of Clinical Pharmacology|May 23, 2002
Pharmacodynamic modeling of thrombopoietin, platelet, and megakaryocyte dynamics in patients with acute myeloid leukemia undergoing dose intensive chemotherapySteven H Bernstein, William J Jusko, Wojciech Krzyzanski, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 8, 2013
Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease statesMaria Serena Longhi, Simon C Robson, Steven H Bernstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
Follicular lymphoma intratumoral CD4+CD25+GITR+ regulatory T cells potently suppress CD3/CD28-costimulated autologous and allogeneic CD8+CD25- and CD4+CD25- T cellsShannon P Hilchey, Asit De, Lisa M Rimsza, et al.
Pageof 6